Stay updated on Nivolumab in Type B3 Thymoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Type B3 Thymoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Publications section wording updated to clarify PubMed-sourced publications and add Revision: v3.3.2; the prior PubMed description was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:22:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page no longer displays the government funding status notice; core study details and eligibility information remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T19:14:43.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The updates appear to be cosmetic changes to the page layout and navigation. Core study information such as eligibility criteria, outcomes, and enrollment remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T13:44:34.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Significant changes: updated operating status notice and version to v3.2.0; removed previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T02:15:52.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version metadata updated from v3.0.2 to v3.1.0. No other content changes.
    Difference
    0.1%
    Check dated 2025-09-28T23:26:24.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Updated to Revision: v3.0.2 and removed the 'Back to Top' element. No other substantive content changes were detected.
    Difference
    0.2%
    Check dated 2025-09-14T09:54:06.000Z thumbnail image

Stay in the know with updates to Nivolumab in Type B3 Thymoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.